Results 111 to 120 of about 1,005 (173)

Synaptic histamine shapes the neurocomputational dynamics of human learning

Colwell MJ, van Uum F, Cowen PJ, Martens M, Browning M, Barron H, Harmer CJ, Murphy S.   +7 more
europepmc   +1 more source

Voluntary self-reclusion (Hikikomori) across cultures: A conceptual viewpoint. [PDF]

Indian J Psychiatry
Biswas T, Mohapatra D, Panigrahi S.
europepmc   +1 more source

Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/Inverse Agonist Pitolisant in Prader-Willi Syndrome. [PDF]

Psychopharmacol Bull
Freitas B, Teodoro TP.
europepmc   +1 more source

Very late onset narcolepsy type 1: a case report and review of the literature. [PDF]

J Clin Sleep Med
Martens J, Van Den Bossche M.
europepmc   +1 more source

Effect of sleep apnoea interventions on multiple health outcomes: an umbrella review of meta-analyses of randomised controlled trials. [PDF]

EClinicalMedicine
Figard C, Ben Messaoud R, Baillieul S, Joyeux-Faure M, Destors M, Tamisier R, Khouri C, Pépin JL.   +7 more
europepmc   +1 more source

Pharmacological inhibition of histamine N-methyltransferase extends wakefulness and suppresses cataplexy in a mouse model of narcolepsy. [PDF]

Sleep
Naganuma F, Girgin B, Agu ABS, Hirano K, Nakamura T, Yanai K, Vetrivelan R, Mochizuki T, Yanagisawa M, Yoshikawa T.   +9 more
europepmc   +1 more source

Narcolepsy: Beyond the Classic Pentad. [PDF]

CNS Drugs
Morse AM, Kim SY, Harris S, Gow M.
europepmc   +1 more source

Epidemiology, patient characteristics, and treatment patterns of patients with narcolepsy in Sweden: a non-interventional study using secondary data. [PDF]

Sleep Adv
Giertz A, Mesterton J, Jakobsson T, Crawford S, Ghosh S, Landtblom AM.   +5 more
europepmc   +1 more source

Armodafinil as Monotherapy in Treating Narcolepsy with Cataplexy. [PDF]

Cureus
Ahmed A, Tariq S, Khan SJ, Shah ZH.
europepmc   +1 more source